{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:23:43Z","timestamp":1774632223439,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR42389\/MED\/30\/2351\/2021"],"award-info":[{"award-number":["BT\/PR42389\/MED\/30\/2351\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12072-025-10919-y","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:17:52Z","timestamp":1762867072000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recombinant albumin in cirrhosis: can this be a reality?"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0007-5718","authenticated-orcid":false,"given":"Madhusudana Girija","family":"Sanal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"10919_CR1","first-page":"268","volume":"7","author":"M Garcovich","year":"2009","unstructured":"Garcovich M, Zocco MA, Gasbarrini A. Clinical use of albumin in hepatology. Blood Transfus. 2009;7:268\u2013277","journal-title":"Blood Transfus"},{"key":"10919_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.gastro.2023.10.016","volume":"166","author":"G Garcia-Tsao","year":"2024","unstructured":"Garcia-Tsao G, Abraldes JG, Rich NE, Wong VW-S. AGA clinical practice update on the use of vasoactive drugs and intravenous albumin in cirrhosis: expert review. Gastroenterology. 2024;166:202\u2013210","journal-title":"Gastroenterology"},{"key":"10919_CR3","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jhep.2022.03.005","volume":"76","author":"P Caraceni","year":"2022","unstructured":"Caraceni P, O\u2019Brien A, Gines P. Long-term albumin treatment in patients with cirrhosis and ascites. J Hepatol. 2022;76:1306\u20131317","journal-title":"J Hepatol"},{"key":"10919_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa2022166","volume":"384","author":"L China","year":"2021","unstructured":"China L, Freemantle N, Forrest E, Kallis Y, Ryder SD, Wright G, et al. A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N Engl J Med. 2021;384:808\u2013817","journal-title":"N Engl J Med"},{"key":"10919_CR5","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1002\/hep.31836","volume":"74","author":"RK Jagdish","year":"2021","unstructured":"Jagdish RK, Maras JS, Sarin SK. Albumin in advanced liver diseases: the good and bad of a drug! Hepatology. 2021;74:2848\u20132862","journal-title":"Hepatology"},{"key":"10919_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/iub.70024","volume":"77","author":"L Ivanciu","year":"2025","unstructured":"Ivanciu L, Camire RM. Blood coagulation factor IX: structure, function, and regulation. IUBMB Life. 2025;77: e70024","journal-title":"IUBMB Life"},{"issue":"Suppl 4","key":"10919_CR7","first-page":"s2","volume":"11","author":"G Grazzini","year":"2013","unstructured":"Grazzini G, Mannucci PM, Oleari F. Plasma-derived medicinal products: demand and clinical use. Blood Transfus. 2013;11(Suppl 4):s2-5","journal-title":"Blood Transfus"},{"key":"10919_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125527","volume":"245","author":"H Tan","year":"2023","unstructured":"Tan H, Ji Y, Lei H, Wang F, Dong H, Yang S, et al. Large-scale and cost-effective production of recombinant human serum albumin (rHSA) in transgenic Bombyx mori cocoons. Int J Biol Macromol. 2023;245: 125527","journal-title":"Int J Biol Macromol"},{"key":"10919_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pep.2018.04.012","volume":"149","author":"S Li","year":"2018","unstructured":"Li S, Li L, Chen Z, Xue G, Jiang L, Zheng K, et al. A novel purification procedure for recombinant human serum albumin expressed in Pichia pastoris. Protein Expr Purif. 2018;149:37\u201342","journal-title":"Protein Expr Purif"},{"key":"10919_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0304-4165(98)00126-3","volume":"1426","author":"TR Gemmill","year":"1999","unstructured":"Gemmill TR, Trimble RB. Overview of N- and O-linked oligosaccharide structures found in various yeast species. Biochim Biophys Acta. 1999;1426:227\u2013237","journal-title":"Biochim Biophys Acta"},{"key":"10919_CR11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1467-7652.2009.00497.x","volume":"8","author":"V Gomord","year":"2010","unstructured":"Gomord V, Fitchette A-C, Menu-Bouaouiche L, Saint-Jore-Dupas C, Plasson C, Michaud D, et al. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J. 2010;8:564\u2013587","journal-title":"Plant Biotechnol J"},{"key":"10919_CR12","doi-asserted-by":"publisher","first-page":"19078","DOI":"10.1073\/pnas.1109736108","volume":"108","author":"Y He","year":"2011","unstructured":"He Y, Ning T, Xie T, Qiu Q, Zhang L, Sun Y, et al. Large-scale production of functional human serum albumin from transgenic rice seeds. Proc Natl Acad Sci U S A. 2011;108:19078\u201319083","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10919_CR13","doi-asserted-by":"crossref","unstructured":"Wang X, Li W, Kong F, Guo X, Jin Q, Gao R, Hu Y, Cai Y, Xin G, Ji H, Piao H, Fu Z, Wang Y, Piao Z, Wang S, Hua R, Wen X, Qi Y, Jin J, Wang C, Wang Z, Xu F, Zhou Q, Li X, Yu G, Wang Y, Yang T, Xiang W, Pan Y, Niu J, Gao Y. A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascites. Hepatol Int. 2025","DOI":"10.1007\/s12072-025-10871-x"},{"key":"10919_CR14","unstructured":"JIHO,Inc. PJ. COMMENTARY\/Medway Data Falsification to Make Blood Product Self-Sufficiency Difficult | PHARMA JAPAN (jiho.jp) [Internet]. PHARMA JAPAN. 2009 [cited 2025 Jul 16]. Available from: https:\/\/pj.jiho.jp\/article\/p-1300861893826?form=MG0AV3&form=MG0AV3"},{"key":"10919_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-335577","author":"J Niu","year":"2025","unstructured":"Niu J, Gao Y, Wang G, Qin Z, Wu C, Yu Z, et al. Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial. Gut. 2025. https:\/\/doi.org\/10.1136\/gutjnl-2025-335577","journal-title":"Gut"},{"issue":"1","key":"10919_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-08249-8","volume":"8","author":"J Nilsen","year":"2025","unstructured":"Nilsen J, Aaen KH, Benjakul S, Ruso-Julve F, Greiner TU, Bejan D, et al. Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end. Commun Biol. 2025;8(1): 810","journal-title":"Commun Biol"},{"key":"10919_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/protein\/gzt023","volume":"26","author":"M Schlapschy","year":"2013","unstructured":"Schlapschy M, Binder U, B\u00f6rger C, Theobald I, Wachinger K, Kisling S, et al. PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins. Protein Eng Des Sel. 2013;26:489\u2013501","journal-title":"Protein Eng Des Sel"},{"key":"10919_CR18","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1039\/D5LC00131E","volume":"25","author":"F Del Bono","year":"2025","unstructured":"Del Bono F, Di Trani N, Demarchi D, Grattoni A, Motto Ros P. Active implantable drug delivery systems: engineering factors, challenges, opportunities. Lab Chip. 2025;25:3608\u20133629","journal-title":"Lab Chip"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10919-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10919-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10919-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:41:36Z","timestamp":1771598496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10919-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10919"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10919-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Madhusudana Girija Sanal and Shiv Kumar Sarin declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}